Alcon (ALC)
(Delayed Data from NYSE)
$85.54 USD
-2.28 (-2.60%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $85.87 +0.33 (0.39%) 7:58 PM ET
4-Sell of 5 4
C Value C Growth D Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, Alcon has a PEG ratio of 2.32 compared to the Medical - Instruments industry's PEG ratio of 2.21.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ALC 85.54 -2.28(-2.60%)
Will ALC be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ALC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ALC
Alcon Stock Gains Following UNITY VCS' Approval in Canada
Glaukos Ramps Up iDose TR, Battles Legacy and Reimbursement Risks
ALC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Do Options Traders Know Something About Alcon Stock We Don't?
Is it Apt to Retain Alcon Stock in Your Portfolio for Now?
COO Q2 Earnings Signal Growth and Caution: How to Play the Stock?
Other News for ALC
Alcon Agrees to Acquire STAAR Surgical | ALC Stock News
Tracking William Von Mueffling's Cantillon Capital Management Portfolio - Q2 2025 Update
STAAR Surgical: Takeover Offer Comes At A Significant Premium
Alcon (ALC) to Acquire STAAR Surgical in $1.5 Billion Deal
Alcon to acquire Staar Surgical for $28 per share in cash